Loading clinical trials...
Loading clinical trials...
A Clinical Study of CD30 Targeted CAR-T in Treating CD30-Expressing Lymphomas
Conditions
Interventions
ICAR30 T cells
Locations
1
China
Weifang People's Hospital
Weifang, Shandong, China
Start Date
March 1, 2017
Primary Completion Date
December 31, 2020
Completion Date
December 31, 2025
Last Updated
December 27, 2017
NCT05529069
NCT07388563
NCT06189391
NCT05006716
NCT06026319
NCT06561048
Lead Sponsor
Immune Cell, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions